Inactive Instrument

Highlights Echo Therapeutics, Inc.

Equities

ECTE

US27876L2060

Highlights

Unlock all the news: Be the first to know and act before the market!

Echo Therapeutics, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2016	12/08/16	CI
Echo Therapeutics, Inc. Announces Institutional Review Board Approval of New Protocol	13/06/16	CI
Echo Therapeutics Seeks Acquisitions	10/06/16	CI
Echo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2016	20/05/16	CI
Echo Therapeutics, Inc. Reports Consolidated Earnings Results for the Year Ended December 31, 2015	30/03/16	CI
Echo Therapeutics, Inc. Announces Earnings Results for the Third Quarter Ended September 30, 2015	16/11/15	CI
Echo Therapeutics, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2015	14/08/15	CI
Worldwide Business with kathy ireland® Selects Echo Therapeutics, Inc. for Wearable Technology Feature	26/05/15	CI
Echo Therapeutics, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015	15/05/15	CI
Echo Therapeutics, Inc. Reports Consolidated Earnings Results for the Year Ended December 31, 2014	16/04/15	CI
Echo Therapeutics, Inc. Achieves Wireless Mobile Communication Milestone	30/03/15	CI
Echo Therapeutics and Medical Technologies Innovation Asia Re-Affirm Operational Partnership	21/01/15	CI
Echo Therapeutics, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014	19/11/14	CI
Echo Therapeutics, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014	14/08/14	CI
Echo Therapeutics, Inc. Signs License, Development and Commercialization Agreement with Medical Technologies Innovation Asia, Ltd	13/12/13	CI
Echo Therapeutics, Inc. Announces Positive Results from Multi-Center Clinical Trial of Symphony CGM System	26/11/13	CI
Echo Therapeutics, Inc. Submits Pre-Submission Package to FDA for Symphony CGM System	10/06/13	CI
Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony(R) CGM System	05/06/13	CI
Echo Therapeutics, Inc. Announces Institutional Review Board Approval for its Clinical Trial of the Symphony(R) CGM System	21/05/13	CI
Echo Therapeutics, Inc. Presents Positive Clinical Trial Results of the Symphony(R) tCGM System	22/01/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Echo Therapeutics, Inc.

Equities

ECTE

US27876L2060

Highlights

Filters